L6J.F AIFORIA TECHNOLOGIES OYJ

Healthcare Health Care Technology Frankfurt Exchange
0.8120 EUR
Close of Nov 12, 2026
0.7740 2.56
Market cap
EUR 30.4M
P/E
-
P/B
1.84x
ROE
-74.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is L6J.F undervalued?

Graham number

The Graham number of AIFORIA TECHNOLOGIES OYJ cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

AIFORIA TECHNOLOGIES OYJ fundamental analysis

No fundamental analysis for AIFORIA TECHNOLOGIES OYJ yet.

AIFORIA TECHNOLOGIES OYJ stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About AIFORIA TECHNOLOGIES OYJ

Aiforia Technologies Oyj, together with its subsidiary, Aiforia Inc., provides AI-based image analysis software used in clinical, preclinical, and academic laboratories to pathologists and researchers in Finland, rest of Europe, North America, and internationally. It offers tools for AI-supported diagnostics and visualization of patient samples, as well as automated screening and reporting tools for the treatment of various cancers, such as breast, lung, and prostate cancer;…

Full company profile